血管活性药物评分在危重症患者中临床应用现状

Clinical application of vasoactive inotropic score in critically ill patients

休克是众多危重症患者疾病进展的共同终末阶段,在补液对症治疗后仍无法维持血流动力学稳定的情况下,临床上通常会使用血管活性药物来改善休克患者机体微循环。现有研究表明血管活性药物的大量使用与患者不良结局相关,血管活性药物评分系统也逐渐成为一种有效的预后预测工具。本文就血管活性药物评分在危重症患者中的临床应用研究进行综述,分析评分在不同情况下的使用及缺陷,探究其未来可能的发展方向,以期为血管活性药物评分系统的进一步改良提供帮助。

Shock is the common end stage of disease progression in most critically ill patients.When hemodynamic stability cannot be maintained after symptomatic treatment with fluid rehydration,vasoactive drugs are usually used to improve the microcirculation of shock patients.Many studies have shown that the extensive doses use of vasoactive drugs is associated with adverse outcomes,and vasoactive drug scoring system has gradually become an effective prognostic tool in critically ill patients.This article reviews the clinical application of vasoactive drug scoring in critically ill patients,analyzes the use and defects of the score in different situations,and explores its possible development direction in the future.The aim of the review is to provide assistance for further improvement of vasoactive drug scoring system.